ctrl K

Enliven Therapeutics Inc. (ELVN)

NASDAQ: ELVN · Real-Time Price · USD

18.57

-0.08 (-0.43%)

At close: Apr 30, 2025, 9:41 AM

Enliven Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
PE Ratio	-11.9	-6.87	-2.71	-2.85	-16.22	-11.05	-22.86	n/a
PEG Ratio	1.99	0.10	-0.03	0.04	-0.1	-0.1	n/a	n/a
PS Ratio	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
PB Ratio	3.42	2.00	-1.33	-1.64	-15.12	-5.31	-9.85	-16.69
P/FCF Ratio	-14.46	-8.01	-3.13	-3.64	-34.15	-11.77	-29.53	-29.51
P/OCF Ratio	-14.47	-8.03	-3.19	-3.68	-36	-11.85	-29.53	-29.51
OCF/S Ratio	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt / Equity Ratio	n/a	0.00	-0.00	-0.00	-0.01	n/a	n/a	-0.04
Quick Ratio	19.99	10.28	8.00	19.24	88.35	7.29	4.21	12.38
Current Ratio	19.99	10.28	8.00	19.24	88.35	7.29	4.21	12.38
Asset Turnover	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Interest Coverage	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Return on Equity	-0.29	-0.29	0.49	0.58	0.93	0.48	0.43	n/a
Return on Assets	-0.27	-0.26	-0.45	-0.22	-0.14	-0.7	-1.47	n/a
Return on Invested Capital	-0.34	-0.34	-0.53	-0.23	-0.07	-0.85	-1.69	n/a
Dividend Yield	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Net Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Profit Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
FCF Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
EBITDA Margin	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a